Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001749475-21-000002
Filing Date
2021-05-12
Accepted
2021-05-12 11:44:45
Documents
1
Effectiveness Date
2021-05-12
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6949
  Complete submission text file 0001749475-21-000002.txt   8177
Mailing Address SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP PLATINUM HOUSE, 21 HA'ARBA'AH ST. TEL AVIV L3 6473921
Business Address SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP PLATINUM HOUSE, 21 HA'ARBA'AH ST. TEL AVIV L3 6473921 972-3-6845535
Sphera Biotech US Fund, L.P. (Filer) CIK: 0001749475 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-323124 | Film No.: 21914209